Plus, news about Kamari Pharma, Leyden Labs, Kiora, Senju, Alto Neuroscience, Chase Therapeutics, Nxera Pharma, Neurocrine Biosciences, Aytu BioPharma and Fabre-Kramer:
On heels of pivotal readout, Vera Therapeutics refinances: The company, which
↧